A Study to Form a Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)

Overview

About this study

The purpose of this study is to form a registry to follow patients with sarcoidosis associated pulmonary hypertension

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria

  • Sarcoidosis as defined by the ATS/WASOG statement
  • Pulmonary hypertension as confirmed by right heart catheterization
  • Provide written informed consent

Exclusion Criteria

  • Unwillingness to provide assurance that they will complete the follow up visits for the study

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Eva Carmona Porquera, M.D., Ph.D.

Open for enrollment

Contact information:

Pulmonary Clinical Research Unit

(800) 753-1606

PCRUE18@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20169933

Mayo Clinic Footer